ImmunAbs Inc.
PrivateLast Round
Grant
Jan 31, 2024
Total Funding Raised
$19.36M
Momentum Score
25 /100
Company Overview
ImmunAbs Inc. is a biotechnology company that develops antibody therapeutics for autoimmune diseases, diabetic retinopathy, and metabolic syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
antibody therapeuticsmonoclonal antibodymAbscomplement C5 inhibitorautoimmune diseasebiologicsdrug developmentMyasthenia Gravisclinical-stage biotechantibody engineeringdrug discoverypharma licensingdiabetic retinopathycomplement systemphage displaysingle B cell cloning
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunAbs Inc. Comps
Public and private peers based on sector, stage, and business model.
ImmunAbs Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 31, 2024 | ||||
| Series B | Nov 30, 2022 | ||||
| Grant | Nov 5, 2021 | ||||
| Series A | Sep 30, 2021 |
ImmunAbs Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| D3 Jubilee Partners | Series B |
| Seoul Investment Partners | Series B, Series A |
| CKD Venture Capital | Series B |
| Korea Drug Development Fund | Grant |
| Hana Securities | Series B |
| Daekyo Investment | Series B, Series A |
| Magna Investment | Series B, Series A |
ImmunAbs Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmunAbs Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersSeoul
Employee Range12
Year Founded2017
Last FundingJan 31, 2024
